| 查看: 442 | 回复: 2 | ||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | ||
[求助]
中译英
|
||
|
项目选题要求 1、 有一定的市场前景，中国国内研发少，有特色的品种。为了使我们合作顺利进行，提高申报速度，公司成立初期以成熟度较高，有一定研发基础的品种为主。 1-2年内不要选全新的品种开发。 2、 后期考虑与你们进行同步研发，选择国内外专利将到期的、或没有专利保护的新品种。 3、 抗肿瘤药以进口注册为主，暂时不考虑开发 4、 降脂药国内竞争太多，暂时不考虑 5、 精神类药物特别是康复类药物可重点考虑 4、 可以考虑有特色的小品种 |
回复此楼» 猜你喜欢
售SCI一区T0P文章，我:8O.55.1.O.5.4,科目齐全,可+急
已经有3人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有3人回复
-
售SCI一区文章，我:8.O.551.O.5.4,科目全,可伽急
已经有3人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有3人回复
-
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有6人回复
-
售一区SCI文章T0P，我:8O.551.O54,科目全,可十急
已经有9人回复
-
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有3人回复
-
考博求助
已经有3人回复
-
售SCI一区文章，我:8.O.551.O.5.4,科目全,可伽急
已经有5人回复
-
售SCI一区T0P文章，我:8.O.55.1.O.5.4,科目全,可+急
已经有4人回复
【答案】应助回帖
|
Requirements of Topic Selection 1、Those with a certain market prospect, less developed in domestic, distinctive varieties should be given the priority. as well as those having . In order to cooperate smoothly and improve the declaration speed, those having high maturity and R & D foundation varieties should be given the first place in the company's initial stage. Don't pick brand-new varieties to develop within one or two years; 2、Synchronous development wil be considered later. And we will choose those soon expiring or no patent protected new varieties both at home and abroad; 3、As for the anti-tumor medicine, take import registration as the principle thing, don't consider its development for the time being; 4、Due to its fierce competition, the development of lipid-lowering medicine is not included in the list; 5、Psychiatric drugs, especially rehabilitation drugs, can be the key consideration 6、Distinctive small varieties can be taken into account. |
2楼2011-09-24 21:30:14
【答案】应助回帖
★ ★
爱与雨下(金币+2): 鼓励新虫~！ 2011-09-24 21:49:43
夏天下雨了(金币+50, 翻译EPI+1): 谢谢 2011-09-25 11:12:25
爱与雨下(金币+2): 鼓励新虫~！ 2011-09-24 21:49:43
夏天下雨了(金币+50, 翻译EPI+1): 谢谢 2011-09-25 11:12:25
|
不好意思，有的改过的地方忘记删掉了！这是整理好的！希望对你能有所帮助！ Requirements of Topic Selection 1、Those with a certain market prospect, less developed in domestic, distinctive varieties should be given the priority. In order to cooperate smoothly and improve the declaration speed, those having high maturity and R & D foundation varieties should be given the first place in the company's initial stage. Don't pick brand-new varieties to develop within one or two years; 2、Synchronous development wil be considered later. And we will choose those soon expiring or no patent protected new varieties both at home and abroad; 3、As for the anti-tumor medicine, take import registration as the principle thing, don't consider its development for the time being; 4、Due to its fierce competition in domestic, the development of lipid-lowering medicine is not included in the list; 5、Psychiatric drugs, especially rehabilitation drugs, can be the key consideration 6、Distinctive small varieties can be taken into account, too. |
3楼2011-09-24 21:37:24
